Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CorMedix Inc
CRMD | US
6.69
USD-0.03
-0.45%
CRMD | US
About CorMedix Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
11/03/2026
Close
6.69
Open
6.73
High
6.83
Low
6.51
CorMedix Inc. a biopharmaceutical company focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis total parenteral nutrition and oncology. The company was formerly known as Picton Holding Company Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights New Jersey.
View LessCRMD | US
Risk
50.4
Sharpe
-0.52
Luna's Score
31/100
Recommendation
Sell
Luna says (CRMD | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
70.0%1 month
50.4%3 months
84.6%6 months
74.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
17.79
Price to book
13.12
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-3.50
Ent. to rev.
695.80
PEG
-
Other Fundamentals
EBITDA
-58.01M
MarketCap
386.42M
MarketCap(USD)
386.42M
Div. yield
-
Op. margin
-1.90K
Erngs. growth
-
Rev. growth
-47.30
Ret. on equity
-111.55
Short ratio
9.45
Short perc.
16.60
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
1.31
Range1M
1.73
Range3M
6.89
Volumes: Market Activity
Rel. volume
0.83
Price X volume
9.34M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.50 | - | Cheaper |
| Ent. to Revenue | 695.80 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 13.12 | 15.55 | Par |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 84.62 | - | Par |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 386.42M | - | Emerging |
